Cargando…

Prognostic Role of Prothrombin Time Activity, Prothrombin Time, Albumin/Globulin Ratio, Platelets, Sex, and Fibrinogen in Predicting Recurrence-Free Survival Time of Renal Cancer

BACKGROUND: To help with the clinical practice of renal cancer patients, prognostic models are urgently warranted. We hunted and identified prognostic variables associated with recurrence-free survival (RFS) for renal cancer patients. PATIENTS AND METHODS: In this retrospective study, 187 renal canc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bian, Zichen, Meng, Jialin, Niu, Qingsong, Jin, Xiaoyan, Wang, Jinian, Feng, Xingliang, Che, Hong, Zhou, Jun, Zhang, Li, Zhang, Meng, Liang, Chaozhao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505717/ https://www.ncbi.nlm.nih.gov/pubmed/32982441 http://dx.doi.org/10.2147/CMAR.S264856

Ejemplares similares

The progress of prothrombin time measurement
por: Horsti, Juha
Publicado: (2009)

Prothrombin Time in Normal Indians
por: Braganca, Beatriz M., et al.
Publicado: (1946)

Anemia-Associated Platelets and Plasma Prothrombin Time Increase in Patients with Adenomyosis
por: Lin, Qiao, et al.
Publicado: (2022)

Effect of storage conditions on prothrombin time, activated partial thromboplastin time and fibrinogen concentration on canine plasma samples
por: Piccione, Giuseppe, et al.
Publicado: (2010)

FRACTIONATION OF PLASMA GLOBULIN FOR PROTHROMBIN, THROMBOKINASE, AND ACCESSORY THROMBOPLASTIN
por: Milstone, J. H.
Publicado: (1951)

Comparison of Prothrombin Time Derived From CoaguChek XS and Laboratory Test According to Fibrinogen Level
por: Kim, Sue Jung, et al.
Publicado: (2014)

A retrospective discussion of the prognostic value of combining prothrombin time(PT) and fibrinogen(Fbg) in patients with Hepatocellular carcinoma
por: Wang, Xue-Ping, et al.
Publicado: (2017)

A New Generation Prothrombin Time Method for INR
por: Horsti, Juha, et al.
Publicado: (2008)

Prothrombin Time in Health and Disease. (According to Quick's Method)
por: Reddy, D. V. S., et al.
Publicado: (1941)

Clinical Significance of Prothrombin Time in Cholangiocarcinoma Patients with Surgeries
por: Wang, Hui-shan, et al.
Publicado: (2019)

The Effect of Sugammadex on Prothrombin and Activated Partial Thromboplastin Time
por: Samara, Evangelia, et al.
Publicado: (2021)

Replacement of traditional prothrombin time monitoring with the new Fiix prothrombin time increases the efficacy of warfarin without increasing bleeding. A review article
por: Onundarson, Pall T., et al.
Publicado: (2021)

Novel Prognostic Scores Based on Plasma Prothrombin Time and Fibrinogen Levels in Patients With AFP-Negative Hepatocellular Carcinoma
por: Mao, Minjie, et al.
Publicado: (2020)

Preclinical evaluation of point‐of‐care prothrombin time as a biomarker test to guide prothrombin replacement therapy in coagulopathic bleeding
por: Balendran, Clare A., et al.
Publicado: (2017)

Pneumatic tube system transport does not alter platelet function in optical and whole blood aggregometry, prothrombin time, activated partial thromboplastin time, platelet count and fibrinogen in patients on anti-platelet drug therapy
por: Enko, Dietmar, et al.
Publicado: (2017)

Should we test the prothrombin time in anticoagulated epistaxis patients?
por: Soyka, Michael B., et al.
Publicado: (2013)

Plasma Prothrombin Time and Esophageal Varices in Patients with Cirrhosis of Liver
por: Islam, Md Nasirul, et al.
Publicado: (2016)

Interference of M-protein on prothrombin time test – case report
por: Margetić, Sandra, et al.
Publicado: (2016)

Therapeutic monitoring of rivaroxaban in dogs using thromboelastography and prothrombin time
por: Bae, Junwoo, et al.
Publicado: (2019)

Data mining for prothrombin time and international normalized ratio reference intervals in children
por: Shaikh, Muhammad Shariq, et al.
Publicado: (2022)

Genetic Polymorphisms Associated with Prothrombin Time and Activated Partial Thromboplastin Time in Chinese Healthy Population
por: Zhang, Fan, et al.
Publicado: (2022)

Prothrombin time is predictive of low plasma prothrombin concentration and clinical outcome in patients with trauma hemorrhage: analyses of prospective observational cohort studies
por: Balendran, Clare A., et al.
Publicado: (2017)

Factors That Determine the Prothrombin Time in Patients With Atrial Fibrillation Receiving Rivaroxaban
por: Huang, Jen-Hung, et al.
Publicado: (2018)

FVIII inhibitors display FV‐neutralizing activity in the prothrombin time assay
por: Arsiccio, Andrea, et al.
Publicado: (2021)

The Prognostic Role of Prothrombin Time and Activated Partial Thromboplastin Time in Patients with Newly Diagnosed Multiple Myeloma
por: Geng, Chuanying, et al.
Publicado: (2021)

Diagnostic and Prognostic Significance of the Prothrombin Time/International Normalized Ratio in Sepsis and Septic Shock
por: Schupp, Tobias, et al.
Publicado: (2022)

Normalization of blood clotting characteristics using prothrombin complex concentrate, fibrinogen and FXIII in an albumin based fluid: experimental studies in thromboelastometry
por: Koller, Tobias, et al.
Publicado: (2021)

Predictive Value of the Prothrombin Time-International Normalized Ratio to Albumin Ratio in the Prognosis of Patients with Hepatitis B Virus-Related Acute-on-Chronic Liver Failure
por: Sheng, Yunjian, et al.
Publicado: (2023)

A case of congenital prothrombin deficiency with two concurrent mutations in the prothrombin gene
por: Mansory, Eman M., et al.
Publicado: (2021)

Role of thromboelastography in the evaluation of septic shock patients with normal prothrombin time and activated partial thromboplastin time
por: Kim, Sang-Min, et al.
Publicado: (2021)

D-Dimer and Prothrombin Time Are the Significant Indicators of Severe COVID-19 and Poor Prognosis
por: Long, Hui, et al.
Publicado: (2020)

Prothrombin Time-International Normalized Ratio Predicts the Outcome of Atrial Fibrillation Patients Taking Rivaroxaban
por: Chao, Tze-Fan, et al.
Publicado: (2022)

Enhancing the Quality of Rivaroxaban Exposure Estimates Using Prothrombin Time in the Absence of Pharmacokinetic Sampling
por: Solms, Alexander, et al.
Publicado: (2019)

Four-factor prothrombin complex concentrate improves thrombin generation and prothrombin time in patients with bleeding complications related to rivaroxaban: a single-center pilot trial
por: Schenk, Bettina, et al.
Publicado: (2018)

Prothrombin Time, Activated Partial Thromboplastin Time, and Fibrinogen Reference Intervals for Inbred Strain 13/N Guinea Pigs (Cavia porcellus) and Validation of Low Volume Sample Analysis
por: Condrey, Jillian A., et al.
Publicado: (2020)

Globulin, the albumin-to-globulin ratio, and fibrinogen perform well in the diagnosis of Periprosthetic joint infection
por: Wang, Huhu, et al.
Publicado: (2021)

A sensitivity comparison of the Quick and Owren prothrombin time methods in oral anticoagulant therapy
por: Horsti, Juha
Publicado: (2009)

Prolonged prothrombin time at admission predicts poor clinical outcome in COVID-19 patients
por: Wang, Lang, et al.
Publicado: (2020)

The effect of vitamin K on prothrombin time in critically ill patients: an observational registry study
por: Dahlberg, Sofia, et al.
Publicado: (2021)

The effects of hemolysis on plasma prothrombin time and activated partial thromboplastin time tests using photo-optical method
por: Hernaningsih, Yetti, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_f6ne6rvh7m2gvfbjfr19l6uo79